Skip to main navigation Skip to search Skip to main content

Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in colombian patients with AIDS for diagnosis and follow-up during therapy

  • Diego H. Caceres
  • , Christina M. Scheel
  • , Ángela M. Tob́on
  • , Angela Ahlquist Cleveland
  • , Ángela Restrepo
  • , Mary E. Brandt
  • , Tom Chiller
  • , Beatriz L. Gómez

Research output: Contribution to JournalResearch Articlepeer-review

Abstract

We validated an antigen capture enzyme-linked immunosorbent assay (ELISA) in Colombian persons with AIDS and proven histoplasmosis and evaluated the correlation between antigenuria and clinical improvement during follow-up. The sensitivity of the Histoplasma capsulatum ELISA was 86%, and the overall specificity was 94%. The antigen test successfully monitored the response to therapy.

Original languageEnglish (US)
Pages (from-to)1364-1368
Number of pages5
JournalClinical and Vaccine Immunology
Volume21
Issue number9
DOIs
StatePublished - Sep 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Validation of an enzyme-linked immunosorbent assay that detects Histoplasma capsulatum antigenuria in colombian patients with AIDS for diagnosis and follow-up during therapy'. Together they form a unique fingerprint.

Cite this